Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-25 @ 9:25 PM
Study NCT ID:
NCT01756456
Status:
COMPLETED
Last Update Posted:
2024-04-19
First Post:
2012-12-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.
Sponsor:
Dompé Farmaceutici S.p.A
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
ACTUAL
Primary Completion Date:
2015-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05
Completion Date Type:
ACTUAL
First Submit Date:
2012-12-20
First Submit QC Date:
None
Study First Post Date:
2012-12-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-01
Results First Submit QC Date:
None
Results First Post Date:
2019-07-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-17
Last Update Post Date:
2024-04-19
Last Update Post Date Type:
ACTUAL